Bearish signal on daily chart
Company has spent less than 1% of its operating revenues towards interest expenses and 12.34% towards employee cost in the year ending Mar 31, 2025. (Source: Standalone Financials)
Potential
Upside
1 Year
Target
BUY
Mean Recos by
5 Analysts
0
0
1
2
2
Strong Sell
Sell
Hold
Buy
Strong Buy
/10
Stock Score
Earnings | |
Fundamentals | |
Relative Valuation | |
Risk | |
Price Momentum |
Company has spent less than 1% of its operating revenues towards interest expenses and 12.34% towards employee cost in the year ending Mar 31, 2025. (Source: Standalone Financials)
Niva Bupa Health Insurance Company Ltd. share price moved down by -1.62% from its previous close of Rs 90.76. Niva Bupa Health Insurance Company Ltd. stock last traded price is 89.29
Share Price | Value |
---|---|
Today/Current/Last | 89.2989.25 |
Previous Day | 90.7690.71 |
Do you find these insights useful?
hate it
meh
love it
PE Ratio (x) | 76.40 | ||||||||||
EPS - TTM (₹) | 1.17 | ||||||||||
MCap (₹ Cr.) | 16,313.52 | ||||||||||
Sectoral MCap Rank | 26 | ||||||||||
PB Ratio (x) | 5.42 | ||||||||||
Div Yield (%) | 0.00 | ||||||||||
Face Value (₹) | 10.00 | ||||||||||
Beta Beta
| - | ||||||||||
VWAP (₹) | 90.01 | ||||||||||
52W H/L (₹)BV/Share (₹)MCap/Sales |
|
PE Ratio (x) | 76.37 | ||||||||||
EPS - TTM (₹) | 1.17 | ||||||||||
MCap (₹ Cr.) | 16,306.21 | ||||||||||
Sectoral MCap Rank | 24 | ||||||||||
PB Ratio (x) | 5.42 | ||||||||||
Div Yield (%) | 0.00 | ||||||||||
Face Value (₹) | 10.00 | ||||||||||
Beta Beta
| - | ||||||||||
VWAP (₹) | 89.84 | ||||||||||
52W H/L (₹)BV/Share (₹)MCap/Sales |
|
PE Ratio (x) | 76.40 | ||||||||||
EPS - TTM (₹) | 1.17 | ||||||||||
Dividend Yield (%) | 0.00 | ||||||||||
VWAP (₹) | 90.01 | ||||||||||
PB Ratio (x) | 5.42 | ||||||||||
MCap (₹ Cr.) | 16,313.52 | ||||||||||
Face Value (₹) | 10.00 | ||||||||||
BV/Share (₹) | 16.73 | ||||||||||
Sectoral MCap Rank | 26 | ||||||||||
52W H/L (₹) | 109.34 / 68.54 | ||||||||||
Beta Beta
| - | ||||||||||
MCap/Sales | 2.65 |
PE Ratio (x) | 76.37 | ||||||||||
EPS - TTM (₹) | 1.17 | ||||||||||
Dividend Yield (%) | 0.00 | ||||||||||
VWAP (₹) | 89.84 | ||||||||||
PB Ratio (x) | 5.42 | ||||||||||
MCap (₹ Cr.) | 16,306.21 | ||||||||||
Face Value (₹) | 10.00 | ||||||||||
BV/Share (₹) | 16.73 | ||||||||||
Sectoral MCap Rank | 24 | ||||||||||
52W H/L (₹) | 109.41 / 61.01 | ||||||||||
Beta Beta
| - | ||||||||||
MCap/Sales | 2.65 |
1 Day | -1.62% |
1 Week | 0.68% |
1 Month | 10.21% |
3 Months | 17.8% |
1 Year | N.A. |
3 Years | N.A. |
5 Years | N.A. |
1 Day | -1.6% |
1 Week | 0.75% |
1 Month | 10.14% |
3 Months | 17.71% |
1 Year | N.A. |
3 Years | N.A. |
5 Years | N.A. |
Check whether Niva Bupa Health Ins belongs to analysts' top-rated companies list?
View Stock ScreenersCurrent
Mean Recos by 5 Analysts
Ratings | Current | 1 Week Ago | 1 Month Ago | 3 Months Ago |
---|---|---|---|---|
Strong Buy | 2 | 2 | 2 | 1 |
Buy | 2 | 2 | 2 | 1 |
Hold | 1 | 1 | 1 | 1 |
Sell | - | - | - | - |
Strong Sell | - | - | - | - |
# Analysts | 5 | 5 | 5 | 3 |
Employee & Interest Expense
Company has spent less than 1% of its operating revenues towards interest expenses and 12.34% towards employee cost in the year ending Mar 31, 2025. (Source: Standalone Financials)Quarterly | Annual | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
---|---|---|---|---|---|
Total Income | 1,626.21 | 1,294.92 | 1,399.87 | 1,208.68 | 1,365.79 |
Total Income Growth (%) | 25.58 | -7.50 | 15.82 | -11.50 | 26.94 |
Total Expenses | 1,420.13 | 1,281.68 | 1,386.85 | 1,220.46 | 1,189.48 |
Total Expenses Growth (%) | 10.80 | -7.58 | 13.63 | 2.60 | 11.03 |
EBIT | 206.08 | 13.24 | 13.02 | -11.78 | 176.31 |
EBIT Growth (%) | 1,456.50 | 1.69 | - | -106.68 | 3,749.61 |
Profit after Tax (PAT) | 206.08 | 13.24 | 13.02 | -18.82 | 157.06 |
PAT Growth (%) | 1,456.50 | 1.69 | - | -111.98 | 3,329.26 |
EBIT Margin (%) | 12.67 | 1.02 | 0.93 | -0.97 | 12.91 |
Net Profit Margin (%) | 12.67 | 1.02 | 0.93 | -1.56 | 11.50 |
Basic EPS (₹) | 1.13 | 0.07 | 0.08 | -0.11 | 0.92 |
Quarterly | Annual | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
---|---|---|---|---|
Total Revenue | 5,529.70 | 4,336.27 | 3,227.32 | 2,158.70 |
Total Revenue Growth (%) | 27.52 | 34.36 | 49.50 | 52.77 |
Total Expenses | 5,316.18 | 4,254.41 | 3,214.78 | 2,355.22 |
Total Expenses Growth (%) | 24.96 | 32.34 | 36.50 | 61.01 |
Profit after Tax (PAT) | 213.52 | 81.85 | 12.54 | -196.53 |
PAT Growth (%) | 160.86 | 552.73 | - | - |
Operating Profit Margin (%) | 3.97 | 2.63 | 1.08 | -9.95 |
Net Profit Margin (%) | 3.97 | 1.98 | 0.43 | -10.46 |
Basic EPS (₹) | 1.22 | 0.51 | 0.09 | -1.42 |
All figures in Rs Cr, unless mentioned otherwise
No reported Profit & Loss Statement are available.
Annual | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
---|---|---|---|---|
Total Assets | 9,760.16 | 6,191.87 | 3,876.57 | 2,738.44 |
Total Assets Growth (%) | 57.63 | 59.73 | 41.56 | 44.20 |
Total Liabilities | 6,703.07 | 4,141.26 | 3,048.81 | 2,232.79 |
Total Liabilities Growth (%) | 61.86 | 35.83 | 36.55 | 68.87 |
Total Equity | 3,057.09 | 2,050.61 | 827.76 | 505.64 |
Total Equity Growth (%) | 49.08 | 147.73 | 63.71 | -12.34 |
Current Ratio (x) | 0.23 | 0.17 | 0.16 | 0.14 |
Total Debt to Equity (x) | 0.08 | 0.12 | 0.30 | 0.49 |
Contingent Liabilities | 0.00 | 103.93 | 56.83 | 45.68 |
All figures in Rs Cr, unless mentioned otherwise
No reported Balance Sheet are available.
Increase in Cash from Investing
Company has used Rs 2347.6 cr for investing activities which is an YoY increase of 24.77%. (Source: Standalone Financials)Annual | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
---|---|---|---|---|
Net Cash flow from Operating Activities | 1,654.16 | 812.53 | 592.51 | 337.82 |
Net Cash used in Investing Activities | -2,347.60 | -1,881.59 | -829.39 | -723.17 |
Net Cash flow from Financing Activities | 770.97 | 1,110.02 | 279.93 | 373.76 |
Net Cash Flow | 77.53 | 40.96 | 43.05 | -11.59 |
Closing Cash & Cash Equivalent | 220.35 | 142.82 | 101.86 | 58.81 |
Closing Cash & Cash Equivalent Growth (%) | 54.29 | 40.21 | 73.19 | - |
Total Debt/ CFO (x) | 0.15 | 0.31 | 0.42 | 0.74 |
All figures in Rs Cr, unless mentioned otherwise
No reported Cash Flow Statement are available.
Annual | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
---|---|---|---|---|
Return on Equity (%) | 6.99 | 3.99 | 1.51 | -38.86 |
Return on Capital Employed (%) | 6.45 | 4.70 | 2.86 | -24.72 |
Return on Assets (%) | 2.18 | 1.32 | 0.32 | -7.17 |
Interest Coverage Ratio (x) | 0.00 | 5.20 | 3.42 | -16.58 |
Asset Turnover Ratio (x) | 0.67 | 0.82 | 0.86 | - |
Price to Earnings (x) | 67.11 | - | - | - |
Price to Book (x) | 4.67 | - | - | - |
EV/EBITDA (x) | 66.89 | - | - | - |
EBITDA Margin (%) | 3.97 | 3.34 | 2.20 | -8.52 |
No reported Financial Ratios are available.
Employee & Interest Expense
Company has spent less than 1% of its operating revenues towards interest expenses and 12.34% towards employee cost in the year ending Mar 31, 2025. (Source: Standalone Financials)
Increase in Cash from Investing
Company has used Rs 2347.6 cr for investing activities which is an YoY increase of 24.77%. (Source: Standalone Financials)
Do you find these insights useful?
hate it
meh
love it
Bullish / Bearish signals for Niva Bupa Health Ins basis selected technical indicators and moving average crossovers.
5 Day EMA Crossover
Bearish signal on daily chart
Appeared on:
Choose from Peers
Choose from Stocks
NAME | 1D | 1W | 1M | 3M | 1Y | 3Y | 5Y |
---|---|---|---|---|---|---|---|
Niva Bupa Health Insurance Company Ltd. Stock Performance | -1.62 | 0.68 | 10.21 | 17.80 | 0.00 | 0.00 | 0.00 |
Star Health Stock Performance | -0.14 | 2.02 | -0.68 | 11.01 | -26.07 | -35.46 | 0.00 |
Add More |
Choose from Peers
Choose from Stocks
NAME | P/E (x) | P/B (x) | ROE % | ROCE % | ROA % | Rev CAGR [3Yr] | OPM | NPM | Basic EPS | Current Ratio | Total Debt/ Equity (x) | Total Debt/ CFO (x) |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Niva Bupa Health Insurance Company Ltd. | 76.40 | 5.34 | 6.99 | 6.45 | 2.18 | 36.40 | 3.97 | 3.97 | 1.22 | 0.23 | 0.08 | 0.15 |
Star Health | 39.44 | 3.61 | 9.14 | 11.35 | 3.10 | 14.78 | 5.34 | 4.01 | 11.01 | 0.18 | 0.07 | 0.34 |
Add More |
Choose from Peers
Choose from Stocks
Do you find these insights useful?
hate it
meh
love it
Category | Mar 2025 | Dec 2024 |
---|---|---|
Promoters | 55.98 | 55.98 |
Pledge | 0.00 | 0.00 |
FII | 8.90 | 8.85 |
DII | 9.67 | 9.78 |
Mutual Funds | 2.68 | 2.80 |
Others | 25.45 | 25.39 |
Category | No. of Shares | Percentage | % Change QoQ |
---|---|---|---|
Promoters | 1,02,26,90,470 | 55.98 % | 0.00 |
Pledge | 0 | 0.00 % | 0.00 |
FII | 16,25,93,344 | 8.90 % | 0.05 |
DII | 17,66,27,005 | 9.67 % | -0.10 |
MF | 4,89,31,630 | 2.68 % | -0.11 |
Others | 46,51,15,579 | 25.45 % | 0.06 |
MF Ownership details are not available.
Meeting Date | Announced on | Purpose | Details |
---|---|---|---|
Jun 29, 2025 | May 28, 2025 | POM | - |
May 07, 2025 | Apr 29, 2025 | Board Meeting | Audited Results |
Mar 29, 2025 | Feb 24, 2025 | POM | - |
Feb 04, 2025 | Jan 29, 2025 | Board Meeting | Quarterly Results |
Jan 18, 2025 | Dec 16, 2024 | POM | - |
Dividend announcements are not available.
No other corporate actions details are available.
Niva Bupa Health Insurance Company Ltd., incorporated in the year 2008, is a Small Cap company (having a market cap of Rs 16,313.52 Crore) operating in Financial Services sector. Niva Bupa Health Insurance Company Ltd. key Products/Revenue Segments include Premiums Earned and Other Operating Revenue for the year ending 31-Mar-2024.For the quarter ended 31-03-2025, the company has reported a Standalone Total Income of Rs 1,626.21 Crore, up 25.58 % from last quarter Total Income of Rs 1,294.92 Crore and up 19.07 % from last year same quarter Total Income of Rs 1,365.79 Crore. Company has reported net profit after tax of Rs 206.08 Crore in latest quarter.The company’s top management includes Mr.Chandrashekhar Bhaskar Bhave, Mr.Krishnan Ramachandran, Mr.Carlos Antonio Jaureguizar Ruiz Jarabo, Mr.David Martin Fletcher, Ms.Divya Sehgal, Mr.Maninder Singh Juneja, Mr.Penelope Ruth Dudley, Ms.Geeta Dutta Goel, Mr.Pradeep Pant, Mr.Rajat Sharma. Company has S R Batliboi & Co. LLP as its auditors. As on 31-03-2025, the company has a total of 182.70 Crore shares outstanding.Niva Bupa Health Ins Share Price Today is Rs. 89.29. On previous day, the Niva Bupa Health Ins Share Price (NSE) closed at Rs. 90.76, featuring among the most traded securities on the National Stock Exchange.
Shareholdings:
As of 31st Mar, 2025, the promoter held 55.98% of the stake in Niva Bupa Health Ins shares, out of which 0.0% was pledged. On the same date, foreign institutional investors' (FII) holdings of Niva Bupa Health Ins stocks was 8.9% as compared to 8.85% in Dec 2024 with increase of 0.05%. The domestic institutional investors (DII) holdings on 31st Mar, 2025 was 9.67% as compared to 9.78% in Dec 2024 with decrease of 0.11%. Out of the total DII holdings in Niva Bupa Health Ins shares 2.68% was held by mutual funds. The rest including public held is 25.45%. Niva Bupa Health Ins stock price is reflected on both the exchanges - BSE and NSE.
Dividend, Bonus & Split Information:
Niva Bupa Health Ins Dividend: Ever since 2008, Niva Bupa Health Ins dividends has been paid out around 0 times. As on 18 Jul, 2025, 03:59 PM IST, The overall dividend yield for Niva Bupa Health Ins stands at 0.0%. The last dividend paid was on null (Rs. null). The Earnings Per Share (EPS) for quarter ending 31st Mar 2025 is Rs. 1.17.
Niva Bupa Health Ins Bonus: The most recent bonus issue had been in year null around 0 years ago at 0 : 0 ratio. The first bonus issue was announced in null.
Stock Forecast:
After showing 1769.58 Cr. of sales and 0.0% of quarterly net null, there have been multiple ups and downs in the Niva Bupa Health Ins stock prices in the past few weeks. For example, Niva Bupa Health Ins stock price on 11th of July 2025 was around Rs. 88.69. Niva Bupa Health Ins share price now stands at an average of Rs. 89.29. Judging by last week's performance, stock is in up trend.
Niva Bupa Health Ins has a median target price of Rs. 87.6 in 12 months by 5 analysts. They have provided a high estimate of Rs. 100.0 and low estimate of Rs. 76.0 for Niva Bupa Health Ins share.
Historical Prices and Performance:
Niva Bupa Health Ins, incorporated in 2008 is a Mid Cap company (with a market cap of Rs. 16582.09) operating in Financial Services sector.
The Return of Equity (ROE) in last five financial years given by Niva Bupa Health Ins stock was 6.99%, 3.99%, 1.51%, -38.86% and -8.62% respectively.
The Niva Bupa Health Ins share gave a 3 year return of 0.0% as compared to Nifty 50 which gave a return of 0.0%.
Niva Bupa Health Ins announced 0.0% final dividend on null.
Key Metrics:
PE Ratio of Niva Bupa Health Ins is 77.66
Prices/Sales Ratio of Niva Bupa Health Ins is 2.65
Price/Book Ratio of Niva Bupa Health Ins is 5.42
Peer Insights:
Peers are businesses with comparable activities, buisness objectives and affiliation with a particular industry area. For Niva Bupa Health Ins, major competitors and peers include Star Health. As of Dec 2024, the dividend yield of Niva Bupa Health Ins stands at 0.0% while Star Health stand at 0.0% respectively. The PE ratio and PB Ratio of the company are among its competitors stand at 77.66 and 5.42 respectively.
Leadership of Niva Bupa Health Ins :
Rajat Sharma is Co. Secretary & Compl. Officer
Chandrashekhar Bhaskar Bhave is Chairman & Ind.Director
Krishnan Ramachandran is Managing Director & CEO
Pradeep Pant is Independent Director
Geeta Dutta Goel is Independent Director
David Martin Fletcher is Nominee Director
Divya Sehgal is Nominee Director
Maninder Singh Juneja is Nominee Director
Penelope Ruth Dudley is Nominee Director
Carlos Antonio Jaureguizar Ruiz Jarabo is Nominee Director
Show More
Chandrashekhar Bhaskar Bhave
Chairman & Ind.DirectorKrishnan Ramachandran
Managing Director & CEOCarlos Antonio Jaureguizar Ruiz Jarabo
Nominee DirectorDavid Martin Fletcher
Nominee DirectorDivya Sehgal
Nominee DirectorManinder Singh Juneja
Nominee DirectorPenelope Ruth Dudley
Nominee DirectorGeeta Dutta Goel
Independent DirectorPradeep Pant
Independent DirectorRajat Sharma
Co. Secretary & Compl. OfficerIndustry
Key Indices Listed on
Nifty 500, BSE SmallCap, BSE IPO Index, + 10 more
Address
C-98, 1st Floor Lajpat Nagar, Part 1, South Delhi,New Delhi, Delhi - 110024
DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).
DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.
By using this site, you agree to the Terms of Service and Privacy Policy.